Growth Investing in 2025 — Where Will Value Accrue in Later-Stage Medtech? | LSI USA '25

This panel took place at LSI USA '25 Emerging Medtech Summit in Dana Point, CA.Industry experts from Signet Healthcare Partners, Buenavista Equity Partners, Windham Capital Partners, and more discuss key trends and pinpoint where investors will find value in later-stage medtech by 2025.This panel featured:Brian Rowett — Goldman SachsAshley Friedman — Signet Healthcare PartnersBibi Sattar Marques — Buenavista Equity PartnersCraig Matturo — 1315 CapitalDavid Kereiakes — Windham Capital PartnersJoin us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summitsFollow us on social!LinkedIn: https://www.linkedin.com/company/life-science-intelligence/Twitter: https://twitter.com/lsintelligenceInstagram: https://www.instagram.com/lifescienceintelligence/Facebook: https://www.facebook.com/LifeScienceIntelligence/Subscribe to our YouTube: https://www.youtube.com/channel/UCxAwCTpHCMTScEJbgW7Scjw

There are no comments yet.

Please log in to write the first comment.